These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

165 related articles for article (PubMed ID: 21706830)

  • 1. [A case of chronic inflammatory demyelinating polyradiculoneuropathy concomitant with acquired von Willebrand syndrome].
    Ueda M; Kawamura N; Tateishi T; Shigeto H; Ohyagi Y; Kira J
    Rinsho Shinkeigaku; 2011 May; 51(5):334-7. PubMed ID: 21706830
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Acquired von Willebrand syndrome in a patient with monoclonal gammopathy of undetermined significance.
    Puronen CE; Josephson NC; Broudy VC
    Blood Coagul Fibrinolysis; 2013 Jun; 24(4):430-2. PubMed ID: 23249617
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Immune-mediated etiology of acquired von Willebrand syndrome in systemic lupus erythematosus and in benign monoclonal gammopathy: therapeutic implications.
    Michiels JJ; Berneman Z; Gadisseur A; van der Planken M; Schroyens W; Budde U; van Vliet HH
    Semin Thromb Hemost; 2006 Sep; 32(6):577-88. PubMed ID: 16977568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Successful use of lenalidomide to treat refractory acquired von Willebrand disease associated with monoclonal gammopathy.
    Green A; Shen YP; Nelson AT; Sarode R; Ibrahim IF; Cao J; Afraz S; Yates SG
    Ann Hematol; 2022 Dec; 101(12):2627-2631. PubMed ID: 36194257
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance.
    Yujiri T; Nakamura Y; Oota I; Nakano K; Tanizawa Y
    Ann Hematol; 2014 Aug; 93(8):1427-8. PubMed ID: 24337448
    [No Abstract]   [Full Text] [Related]  

  • 6. [A case of severe chronic inflammatory demyelinating polyradiculoneuropathy with monoclonal gammopathy of undetermined significance with alternating immunoglobulin class to IgM from IgA].
    Hayashi S; Nagamine S; Makioka K; Kusunoki S; Okamoto K
    Rinsho Shinkeigaku; 2016 Sep; 56(9):593-9. PubMed ID: 27580763
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Acquired von Willebrand syndrome: a case series of nine patients and literature review].
    Boissier E; Darnige L; Dougados J; Arlet JB; Dupeux S; Georgin-Lavialle S; Caron C; Tapon-Bretaudière J; Pouchot J; Ranque B
    Rev Med Interne; 2014 Mar; 35(3):154-9. PubMed ID: 23746599
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Chronic inflammatory demyelinating polyneuropathy followed by systemic lupus erythematosus and Sjögren syndrome: a case report].
    Hatano T; Fukuda M; Shiotsuki H; Miwa H; Urabe T; Mizuno Y
    Rinsho Shinkeigaku; 2006 Mar; 46(3):203-9. PubMed ID: 16642931
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chronic Inflammatory Demyelinating Polyradiculoneuropathy in Association With Concomitant Diseases: Identification and Management.
    Chen Y; Tang X
    Front Immunol; 2022; 13():890142. PubMed ID: 35860284
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and immediate treatment of acquired von Willebrand syndrome revealed by recurrent cerebral hemorrhage.
    Pineau-Vincent F; Legout A; Besancon-Bergelin A; Alani M; Laribi K; Lemaire P
    Transfus Clin Biol; 2019 Nov; 26(4):356-358. PubMed ID: 31262628
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [Acquired von Willebrand syndrome in three patients and literature review].
    Ouyang HY; Yu ZJ; Yin J; Zhao XJ; Wang ZY; Zhang W; Ma ZN; Su J; Bai X; Ruan CG
    Zhonghua Xue Ye Xue Za Zhi; 2016 Aug; 37(8):692-5. PubMed ID: 27587252
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Low-dosage intravenous immunoglobulin in the management of a patient with acquired von Willebrand syndrome associated with monoclonal gammopathy of undetermined significance.
    Hayashi T; Yagi H; Suzuki H; Nonaka Y; Nomura T; Sakurai Y; Shibata M; Matsumoto M; Yamamoto Y; Fujimura Y
    Pathophysiol Haemost Thromb; 2002; 32(1):33-9. PubMed ID: 12214161
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Successful treatment of acquired von Willebrand syndrome associated with monoclonal gammopathy : Breaking a dangerous bond.
    Jeryczynski G; Agis H; Eichinger-Hasenauer S; Krauth MT
    Wien Klin Wochenschr; 2022 Jun; 134(11-12):478-482. PubMed ID: 35305139
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bortezomib effectiveness in one patient with acquired von Willebrand syndrome associated to monoclonal gammopathy of undetermined significance.
    Ojeda-Uribe M; Caron C; Itzhar-Baikian N; Debliquis A
    Am J Hematol; 2010 May; 85(5):396. PubMed ID: 20425807
    [No Abstract]   [Full Text] [Related]  

  • 15. Lenalidomide as a novel treatment for refractory acquired von Willebrand syndrome associated with monoclonal gammopathy.
    Lavin M; Brophy TM; Rawley O; O'Sullivan JM; Hayden PJ; Browne PV; Ryan K; O'Connell N; O'Donnell JS
    J Thromb Haemost; 2016 Jun; 14(6):1200-5. PubMed ID: 26991062
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Acquired von Willebrand syndromes: clinical features, aetiology, pathophysiology, classification and management.
    Michiels JJ; Budde U; van der Planken M; van Vliet HH; Schroyens W; Berneman Z
    Best Pract Res Clin Haematol; 2001 Jun; 14(2):401-36. PubMed ID: 11686107
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chronic inflammatory demyelinating polyneuropathy and respiratory failure due to phrenic nerve involvement.
    Tataroglu C; Ozkul A; Sair A
    J Clin Neuromuscul Dis; 2010 Sep; 12(1):42-6. PubMed ID: 20808164
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Different electrophysiological profiles and treatment response in 'typical' and 'atypical' chronic inflammatory demyelinating polyneuropathy.
    Kuwabara S; Isose S; Mori M; Mitsuma S; Sawai S; Beppu M; Sekiguchi Y; Misawa S
    J Neurol Neurosurg Psychiatry; 2015 Oct; 86(10):1054-9. PubMed ID: 25424435
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acquired von willebrand syndrome secondary to monoclonal gammopathy of undetermined significance: long-term remission after treatment with bortezomib.
    Saldanha A; Veiga ME; Okazaki E; Rothschild C; Martinez G; Rocha V; Orsi FA; Villaca P
    J Thromb Thrombolysis; 2023 May; 55(4):770-774. PubMed ID: 37000318
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Successful treatment with recombinant factor VIIa of therapy-resistant severe bleeding in a patient with acquired von Willebrand disease.
    Friederich PW; Wever PC; Briët E; Doorenbos CJ; Levi M
    Am J Hematol; 2001 Apr; 66(4):292-4. PubMed ID: 11279642
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.